Companies /Healthcare

Alkermes plc

NASDAQ: ALKS Drug Manufacturers - Specialty & Generic
$41.45
▼ $0.21 (−0.49%) today
Markets closed · 9:01pm ET
24/7 Rating HOLD
12-Month Price Target
$41.39 +0.0% upside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $41.37
Street consensus $56.56
Ours vs. the Street −26.8%
$36.26Conservative$41.37Current$41.39Our Target$56.01Optimistic
12-Month Projection Historical Optimistic Target Conservative
$32$40$48$56Oct 2025Oct 2027Today$56.01$41.39$36.26
$32$40$48$56Oct 2025Oct 2027Today$56.01$41.39$36.26

Analyst Sentiment

19ANALYSTS
Buy1474%
Hold421%
Sell15%
The Bottom Line

Alkermes is fairly valued at current levels. With our price target of $41.39 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Strong analyst consensus (bullish)
+4.1%
Earnings Growth
Significant earnings decline
−3.0%
Volatility Adjustment
Lower volatility stock
+1.5%
Price Position
Trading near 52-week high
+1.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$40$60$80’26’27’28’29’30’31$85.14$47.27$37.45
$40$60$80’26’27’28’29’30’31$85.14$47.27$37.45

Prediction History

ALKS Price Target History Our Target Stock Price
$60$90$120$150Jul 9Oct 2$41.65$41.75
$60$90$120$150Jul 9Oct 2$41.65$41.75
$40$80$120May 28Oct 2$41.65$41.75
$40$80$120May 28Oct 2$41.65$41.75
Date Price Target Stock Price Rating Upside
$41.65 $41.75 HOLD −0.2%
$41.19 $40.85 HOLD +0.8%
$75.85 $43.39 BUY +74.8%
$76.34 $45.97 BUY +66.1%
$76.37 $46.10 BUY +65.7%
$76.69 $47.41 BUY +61.8%
$76.91 $48.33 BUY +59.1%
$77.08 $49.06 BUY +57.1%
Date Price Target Stock Price Rating Upside
$41.65 $41.75 HOLD −0.2%
$41.19 $40.85 HOLD +0.8%
$76.69 $47.41 BUY +61.8%
$77.44 $50.03 BUY +54.8%
$141.08 $52.83 BUY +167.0%
$152.78 $42.69 BUY +257.9%

Frequently Asked Questions

What is the ALKS stock price prediction for 2030?

Looking ahead to 2030, our model projects ALKS could trade at an average price of $46.03, with a potential range between $34.52 and $57.53. This represents a potential 11.3% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is ALKS a buy, sell, or hold right now?

24/7 Wall St. currently rates ALKS as a HOLD. Near fair value (0.0%) Among Wall Street analysts, 14 rate it Buy, 4 rate it Hold, and 1 rate it Sell.

What is the ALKS stock price target in an optimistic scenario?

In our optimistic scenario for ALKS, the stock could reach $56.01 over the next 12 months, representing a 35.4% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.

What is the downside risk for ALKS stock?

In our conservative scenario, ALKS could trade as low as $36.26 over the next 12 months, representing a 12.4% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →